checkAd
    Startseite > Aktien > Clearmind Medicine > Nachrichten
    Clearmind Medicine Aktie
    0,1003
     
    USD
    -16,21 %
    -0,0194 USD
    Letzter Kurs 28.11.23 Nasdaq
    0,1000
     
    USD
    196.900 STK
    Geldkurs 27.11.23
    0,1003
     
    USD
    1.500 STK
    Briefkurs 27.11.23
    ISIN: CA1850532047 · WKN: A3DUN7 · SYM: CMND · Kanada

    Neueste Nachrichten

    Clearmind Applies to Cease Being a Reporting Issuer in Canada
    30.04.24 · globenewswire · Clearmind Medicine
    Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
    17.04.24 · globenewswire · Clearmind Medicine
    Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders
    10.04.24 · globenewswire · Clearmind Medicine
    Clearmind Medicine CEO Issues Letter to Shareholders
    09.04.24 · globenewswire · Clearmind Medicine
    Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression
    27.03.24 · globenewswire · Clearmind Medicine
    Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China
    19.03.24 · globenewswire · Clearmind Medicine
    Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial
    13.03.24 · globenewswire · Clearmind Medicine
    Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange
    13.03.24 · globenewswire · Clearmind Medicine
    Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds
    27.02.24 · globenewswire · Clearmind Medicine
    Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
    23.02.24 · globenewswire · Clearmind Medicine
    Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds
    20.02.24 · globenewswire · Clearmind Medicine
    Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China
    05.02.24 · globenewswire · Clearmind Medicine